In a breast cancer model, tumor and stromal-derived CCL2 induces the recruitment of inflammatory monocytes, while the inhibition of CCL2 signaling blocks this recruitment resulting in attenuation of metastasis [7]. Here, CCL2 is linked to neoplasm.